EntryPoint Capital »

Revolution Medicines shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $669k 3.6k 187.28
2026-03-31 $360k 3.7k 97.25

More positions owned by EntryPoint Capital

Standardaero (SARO)
Howmet Aerospace (HWM)
Benchmark Electronics (BHE)
Capital One Financial (COF)
Hayward Hldgs (HAYW)
Huntington Bancshares Incorporated (HBAN)
Bank of America Corporation (BAC)
RBC Bearings Incorporated (RBC)
Gilead Sciences (GILD)
Avient Corp (AVNT)
Donaldson Company (DCI)
Universal Display Corporation (OLED)
Helios Technologies (HLIO)
HEICO Corporation (HEI)
American Homes 4 Rent Cl A (AMH)

View all positions for EntryPoint Capital

Top funds holding Revolution Medicines

BlackRock
Farallon Capital Management
FMR
Baker Bros. Advisors
Jupiter Topco
Darwin Global Management
Henderson Group
Vanguard Capital Management
Vanguard Portfolio Management
Nextech Invest
Paradigm Biocapital Advisors
UBS Group
State Street Corporation
Geode Capital Management
Wellington Management Company

View all funds holding Revolution Medicines